Skip to main content
  • Donald Danforth Plant Science Center

    Your Only Statewide Network

    Donald Danforth Plant Science Center

    Your Only Statewide Network

  • Bond Life Sciences Center

    Your Voice For Missouri Life Sciences

  • Jordan Valley Innovation Center

    Business Savings Plans

  • Washington University in St. Louis - School of Medicine

    Your Only Statewide Network

  • MRIGlobal

    Your Voice For Missouri Life Sciences

  • Bayer Crop Science

    Business Savings Plans

Visit PROSPER And See What's New In

Workforce Development!


Missouri Biotechnology Association (MOBIO) is the only statewide membership group that speaks with one voice to advance and champion the life sciences in Jefferson City, across the state, and in Washington, D.C. MOBIO represents most extensive and broadest cross-section of life science organizations including businesses, higher education, medical research, start-ups, agri-science and related firms involved in research, development, and commercialization of the life sciences. MOBIO serves to connect, develop, and advance the state’s bioscience community.

MOBIO members benefit from a strategic focus to support the enrichment and growth of the biosciences in Missouri through:

Statewide Network

MOBIO connections make a difference, specializing in meaningful business-to-business engagements and bridging: 

  • A network of diversified thought leaders
  • Business leaders with policymakers
  • Entrepreneurs with investors
  • Members to greater market potential 

Members connect at regional, national, and international levels with science, education, and commercial networks to advance business and enrich the industry. 

MOBIO is the catalyst, accelerating growth and leveraging high-value relationships for our vibrant life sciences community. 

Science & Policy

MOBIO advocates for Missouri’s life sciences and technology sectors.  Maintaining a sophisticated understanding of current dynamics, MOBIO serves as your trusted voice for bipartisan engagement and leadership within the Missouri State Capitol.

  • MOBIO forges meaningful relationships between public and private sector leaders to:
  • Defend companies large and small
  • Obtain and safeguard public investment
  • Secure state funding for Missouri's life science industry 

The strength of MOBIO's collective voice consistently delivers a compelling message to advance pro-science, pro-business legislative policy.    

Member Savings

MOBIO saves members real money, providing access to numerous partner organizations that offer significant discounts on relevant industry products and services.

  • R & D
  • Laboratory
  • Finance & Administration
  • Facilities & Operations
  • Communications & Data

All MOBIO members are entitled to preferred purchasing power. There is NO fee to participate.

Workforce Development

PROSPER is a workforce development initiative, dedicated to Partnering Resources, Opportunities & Students for Powerful Employment Results. We proudly partner with Missouri Southern State University, MOSO Caps, and Missouri Western State University in the Science 2 Jobs (S2J) program and collaborate with BioSTL and BioNexus KC in the BIOTECH for MO program. PROSPER directly supports these programs and functions as a bridge extending additional assistance to rural and underserved communities within Missouri.

Thank you to the State of Missouri for its support and investment in the current and future growth of Missouri's life sciences.

MOBIO Member Highlight

The Power of Plasma

CSL’s Commitment to Rare Diseases, Emergency Medicine and Women’s Health

CSL is a global biotechnology leader that develops and delivers innovative medicines that save lives, protects public health and helps people with life-threatening medical conditions live full lives. We are driven by our promise to patients and people. We operate one of the world’s largest and most sophisticated plasma collection networks,  – six located in Missouri. 

Donated plasma is used to produce plasma-derived therapies which have a number of important uses including the treatment of rare diseases such as bleeding disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. These therapies are also critical for usage in cardiac surgery, organ transplantation, burn treatments, women’s health and to prevent hemolytic diseases in newborns which can cause brain damage.

Plasma and Rare Diseases 

Plasma-derived therapies are used in the treatment of a number of rare diseases. For example, individuals with an immune deficiency may lack a specific plasma protein or have a malfunctioning version which can lead to serious, and sometimes life-threatening conditions. Plasma-derived therapies take the working proteins from plasma donors and through innovative manufacturing, are converted into therapies to address specific deficiencies. For many conditions, plasma-derived therapies are the only known effective treatment. 

In the last 50 years, plasma-derived therapies have dramatically increased the survival rates for individuals with common variable immune deficiency (CVID), one of the more common immune deficiencies. According to a 2008 study, in 1972, the 12-year survival rate of patients with CVID was 30 percent[1]. However, as of 2008, that rate increased to 91 percent, and has likely only increased since. 

It does take a significant number of plasma donations to treat one patient for a year. For example, for someone with a primary immune deficiency disease, 130 plasma donations are needed to treat that patient for one year. For an individual living with hereditary angioedema, 1,000 plasma donations are needed to treat that individual for a year. These are just a few reasons why plasma donations and an ongoing supply of plasma inventory are very critical.


Plasma and Emergency Medicine

Plasma-derived therapies are used every day to treat patients in the emergency room, operating room and in the intensive care unit. 

In the surgery setting, plasma-derived therapies are used to prevent or treat bleeding for several different causes. For example, patients on blood thinners can be at increased risk of bleeding during surgery. A plasma-derived therapy known as a prothrombin complex can prevent or treat major bleeds in these situations.[2].

Plasma is used on an hourly basis to help treat individuals who have suffered a traumatic injury or are in shock. Albumin, one of the more common plasma-derived therapies, has shown a potential survival benefit when used as a resuscitative fluid for those patients who have sepsis[3]

For those individuals suffering from severe burns, plasma products can treat both the loss of volume of albumin, and low albumin due to their injuries[4][5].


Plasma and Women’s Health

Another key and increasing area where plasma-derived therapies are used to help individuals is in women’s and maternal health. The most common bleeding disorder is von Willebrand disease (VWD) which affects approximately 1% of the world’s population (81 million individuals)[6].

Women who have VWD often have heavy or prolonged menstrual bleeding that can interfere with a woman’s physical, social, emotional and material quality of life. Plasma-derived therapies are often used to help treat VWD, and the effects it has to help decrease the heavy bleeding instances[7].

Pregnant women with VWD are at an increased risk for serious bleeding during and after delivery. Plasma-derived therapies help new mothers have a successful pregnancy, deliver a healthy child and manage post-partum bleeding[8].

In the case of Rh incompatibility - when the pregnant mother is Rh-negative, and the fetus/newborn is Rh-positive - the mother is exposed to the blood of the fetus during pregnancy, labor or birth. When this occurs, the body will recognize the Rh-positive blood and attempt to attack it via antibodies[9]. In these instances, the newborn is at high risk of developing serious medical conditions such as hemolytic disease of the newborn (HDN) which can cause severe brain damage. In countries where plasma-derived therapies are widely available, HDN has been nearly eradicated through education and availability of these therapies to help prevent these complications. 

Donated plasma is critical in the treatment of rare disease, emergency medicine, and women’s health, and CSL is committed to working every day to ensure that we improve the lives of our patients. We encourage Missourians to do the amazing and join us in our commitment to these patients. For more information or to find one of our Missouri locations near you, please visit us at CSL Plasma

[1]Chapel, H, Lucas, M, Lee, M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277-286.

[2]Cleveland Clinic. Warfarin (Coumadin): What it is, Uses & Side Effects. Published June 9, 2023. Accessed September 19, 2023.

[3]Rhodes, A, Evans, LE, Alhazzani, W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Medicine. 2017; 43:304–377.

[4]Mayo Clinic. Burns - Symptoms and Causes. Published August 13, 2022. Accessed September 19, 2023.

[5]U.S. Food & Drug Administration. Albuminex. Published September 14, 2023. Accessed September 19, 2023.

[7]Committee on Adolescent Health Care. Committee Opinion: Screening and Management of Bleeding Disorders in Adolescents with Heavy Menstrual Bleeding (Number 785). American College of Obstetrics and Gynecology; 2019.

[8]James, P, Hames, AH. Von Willebrand disease (VWD): Gynecologic and obstetric considerations. UpToDate; 2023.

[9]American College of Obstetricians and Gynecologists. The Rh Factor: How It Can Affect Your Pregnancy. N.D. Accessed January 10, 2024.

MOBIO Breakthrough

Join us for MOBIO's Breakthrough of the Month series, where we explore Missouri's new and sometimes hidden biotech industry.  

This is a virtual learning platform for the greater life science community where we highlight and discuss novel discoveries, new business opportunities, and potential partnerships. 

This is a FREE presentation that is open to those in the life-science community. 

Are you interested in featuring your organization or discovery?  Please reach out to us, via email.

Tell Your Story

Please schedule your organization or recommend an area of interest.


Miss a Breakthrough?  No problem, monthly recordings are archived for your convenience.


Invite a coworker or colleague to attend.